# CISATRACURIUM BESYLATE
> **ANDA217725** · Abbreviated New Drug Application (Generic) · Sponsor: CAPLIN · Approved 2023-06-09
## Drug
- **FDA Application Number:** ANDA217725
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CISATRACURIUM BESYLATE
- **Generic name:** CISATRACURIUM BESYLATE
- **Active ingredients:** CISATRACURIUM BESYLATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** CAPLIN
- **Manufacturer:** Caplin Steriles Limited
- **First approval:** 2023-06-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217725)
---
*AI Analytics · CC0 1.0*